Browse the corpus

Histamine was one of the earliest mediators of allergic responses to be identified, with its role in modulating allergy first recognized in 1932. Since this initial discovery, extensive research has established histamine as a multifunctional biogenic amine involved not only in allergic inflammation but also in a broad range of physiological and pathological processes, including autoimmune regulation, gastric acid secretion, hematopoiesis, and neurotransmission.[1] Histamine is ubiquitously distributed throughout the body; however, it is stored in particularly high concentrations within the secretory granules of mast cells, especially in the lung parenchyma and airway mucosa, as well as in circulating basophils, where it is released upon immune activation. Histamine is a potent vasoactive molecule that exerts diverse effects on bronchial smooth muscle, vascular endothelium, and nociceptive sensory nerves, thereby contributing to bronchoconstriction, increased vascular permeability, and pruritus, respectively.[2] Through these actions, histamine plays a central role in orchestrating acute and chronic inflammatory responses. Beyond its classical role in immediate hypersensitivity reactions, histamine is now also recognized as an essential immunomodulator that influences both innate and adaptive immune responses by regulating cytokine production, immune cell differentiation, and leukocyte recruitment.[1] The expanding understanding of histamine's pleiotropic effects has led to the identification of multiple histamine receptor subtypes (H1-H4), each mediating distinct biological functions. These discoveries have significantly advanced our understanding of histamine's involvement in the pathophysiology of inflammatory and immune-mediated diseases, including asthma, autoimmune disorders, and chronic inflammatory conditions. As a result, histamine signaling has emerged as an important therapeutic target, with ongoing research aimed at developing more selective receptor antagonists and modulators to improve treatment efficacy and minimize adverse effects.[3]

Histamine plays a central role in the pathogenesis of both autoimmune and allergic diseases and has therefore been the subject of extensive investigation. The diverse effects of histamine are mediated through differential activation of histamine receptor subtypes on immune, epithelial, and neuronal cells. Urticaria is a common dermatologic condition characterized by pruritic wheals confined to superficial layers of the skin, and angioedema involves similar edematous reactions affecting deeper mucocutaneous tissues. Acute urticaria and angioedema are typically associated with hypersensitivity reactions to allergens such as foods, medications, latex, and other environmental triggers and result from immunoglobulin E (IgE)-mediated mast cell degranulation. In contrast, chronic urticaria and angioedema are often autoimmune in nature and occur in response to circulating IgG autoantibodies directed against the high-affinity IgE receptor FcεRIα or against IgE itself, driving histamine release from basophils and mast cells.[16][17] Allergic rhinitis is an inflammatory disorder of the nasal mucosa caused by an exaggerated immune response to airborne allergens. This condition is characterized by symptoms such as clear rhinorrhea, nasal and palatal pruritus, and sneezing. In severe cases, the reaction may also involve adjacent mucosal tissues, including the conjunctiva and middle ear. The clinical manifestations of allergic rhinitis can be largely attributed to allergen-induced histamine release. Pruritus results from activation of H1 receptors on sensory nerve endings, whereas rhinorrhea is driven by increased mucus secretion mediated by histamine- and eicosanoid-induced stimulation of muscarinic glandular pathways. For decades, H1 receptor antagonists have been the mainstay of therapy for symptom control. More recently, second-generation antihistamines—such as loratadine, cetirizine, and fexofenadine—have become preferred due to their improved receptor selectivity, reduced central nervous system penetration, and lower risk of sedation.[18]

Allergic rhinitis is an inflammatory disorder of the nasal mucosa caused by an exaggerated immune response to airborne allergens. This condition is characterized by symptoms such as clear rhinorrhea, nasal and palatal pruritus, and sneezing. In severe cases, the reaction may also involve adjacent mucosal tissues, including the conjunctiva and middle ear. The clinical manifestations of allergic rhinitis can be largely attributed to allergen-induced histamine release. Pruritus results from activation of H1 receptors on sensory nerve endings, whereas rhinorrhea is driven by increased mucus secretion mediated by histamine- and eicosanoid-induced stimulation of muscarinic glandular pathways. For decades, H1 receptor antagonists have been the mainstay of therapy for symptom control. More recently, second-generation antihistamines—such as loratadine, cetirizine, and fexofenadine—have become preferred due to their improved receptor selectivity, reduced central nervous system penetration, and lower risk of sedation.[18] Atopic dermatitis is a chronic, pruritic inflammatory skin condition in which persistent scratching exacerbates skin barrier dysfunction, leading to erythema, edema, fissuring, crusting, and scaling. The acute phase of atopic dermatitis is predominantly mediated by Th2-associated cytokines, whereas the chronic phase is characterized by a shift toward Th1-driven inflammation. Considered a cutaneous manifestation of atopy, atopic dermatitis frequently precedes the development of other atopic disorders, with approximately 50% to 80% of affected children developing asthma or allergic rhinitis by 5 years of age. The complex interplay among Th1 and Th2 lymphocytes, dendritic cells, keratinocytes, and histamine signaling contributes to disease pathophysiology, underscoring the need for further investigation to fully elucidate these mechanisms.[19]

Atopic dermatitis is a chronic, pruritic inflammatory skin condition in which persistent scratching exacerbates skin barrier dysfunction, leading to erythema, edema, fissuring, crusting, and scaling. The acute phase of atopic dermatitis is predominantly mediated by Th2-associated cytokines, whereas the chronic phase is characterized by a shift toward Th1-driven inflammation. Considered a cutaneous manifestation of atopy, atopic dermatitis frequently precedes the development of other atopic disorders, with approximately 50% to 80% of affected children developing asthma or allergic rhinitis by 5 years of age. The complex interplay among Th1 and Th2 lymphocytes, dendritic cells, keratinocytes, and histamine signaling contributes to disease pathophysiology, underscoring the need for further investigation to fully elucidate these mechanisms.[19] Histamine's pathophysiological roles extend beyond allergic and autoimmune conditions. Histamine has recently emerged as a critical regulator of the tumor microenvironment. Studies have demonstrated that histamine modulates interactions between tumor cells and infiltrating immune cells, facilitating multiple immune evasion mechanisms that promote malignant progression.[20] In addition, histamine plays a vital role in hematopoiesis, with both endogenous and exogenous histamine promoting cell cycle progression and proliferation of hematopoietic progenitor cells. Clinically, perturbations in histamine signaling have been linked to adverse hematologic effects; notably, agranulocytosis has been reported in association with certain H2 receptor antagonists, such as cimetidine, and H4 receptor antagonists, such as clozapine, highlighting the broader systemic impact of histamine receptor modulation.[5]